Translational Challenge
Emerging Viral Threats
Tackling the global challenge of viral threats
COVID-19 showed the world what viruses can do to human health and the global economy.
Unfortunately, climate change is causing more human exposure to insects like ticks and mosquitos, and intensive farming increases the risk for animal-to-human infection.
No organisation can solve the problem alone. But we seek to bring our expertise in translational science to help combat the threats of established viruses and new viruses – before the threat from them increases.
What do we want to achieve?
We want to collaborate with others to improve patient lives by:
- addressing the unmet translational needs in low and middle income countries
- developing new treatments and diagnostics
How you can work with us
We collaborate and fund efforts around:
New treatments (particularly monoclonal antibodies or novel modalities)
Low-cost diagnostics (including prognostic biomarkers)
Addressing data gaps
Supporting sustainable capacity building (considering both accessibility and affordability)
Featured partnership
iiCON and the Liverpool School of Tropical Medicine
We are partnering with the Liverpool School of Tropical Medicine (LSTM) to launch a new £2.7 million Translational Development Fund.
Who to contact
-
Julie Brady
Read bio: Julie Brady
-
Magalie Rocheville
Read bio: Magalie Rocheville
Other Global Health Translational Challenges
Neglected Tropical Diseases
Supporting the elimination and control of neglected tropical diseases.
Antimicrobial Resistance
Partnering to fight drug-resistant infections.
Contact us
In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email info@lifearc.org.
Please see our Privacy Policy in relation to the personal data you submit to us through this page.